Professional Documents
Culture Documents
1P.ped2.Viral Infections 3 (IM, CMV, Mumps)
1P.ped2.Viral Infections 3 (IM, CMV, Mumps)
INFECTIOUS MONONUCLEOSIS
Pics
*Exudative tonsillitis
*Strawberry tongue; white strawberry if with whitish plaques
*Bull-neck appearance
Epidemiology
Industrialized countries
Adolescents and young adults
Viral shedding
Oral secretions >6 months after acute
infection then intermittently for life
Male and female secretions
Transmission
Children
Exchange of saliva
Clinical Manifestations
Physical examination
Generalized lymphadenopathy 90%
o Anterior and posterior cervical
o Submandibular
o Axillary and inguinal
o Epitrochlear
Splenomegaly 50%
Hepatomegaly 10%
Rashes 3-15%
Diagnosis
CBC
Ab
VCA:
IgM
VCA:
IgG
Duration
1-3
months
Lifelong
Significance
Best indicator of
primary infection
Marker for prior or
current infection
3-6
months
EA-R
Several wks
Months
to years
EBNA
3-4 months
Lifelong
Indicator of acute
phase
High titer of IgA
anti EA-D is found
in NPC
Indicator of
reactivation
Present in high
titers in EBVassociated Burkitts
lymphoma
Marker for primary
infection
EA-D
Complications
Airway obstruction
Meningitis
Transverse myelitis
Encephalitis
Guillain-Barre syndrome
Hemolytic anemia
Burkitts lymphoma
Nasopharyngeal carcinoma
Attitude is a little thing that makes a big difference.
Winston Churchill
CYTOMEGALOVIRUS INFECTIONS
Epidemiology
Sources of infection
Saliva, breast milk, cervical and vaginal
secretions, urine, semen, stools, blood,
and tissue or organ transplants
Transmission
Direct person-to-person
Indirect through fomites
Perinatal
Clinical Manifestations
Mononucleosis-like syndrome
Fatigue, malaise, myalgia
Headache, fever
Hepatosplenomegaly, liver enzymes
Atypical lymphocytes
Negative heterophile antibody test
Cytomegalic inclusion disease (congenital)
Subclinical 90%
Mild 5%
Severe 5%
Diagnosis
Virus isolation
Massive enlargement of infected cells
(cytomegalic cells) with large intranuclear
and a smaller intracytoplasmic inclusion
bodies
Antigen detection
PCR
Treatment
Ganciclovir + IVIG
Foscarnet
Prevention
Passive immunoprophylaxis
IVIG or CMV IVIG
o Bone marrow transplant
recipients
Active
Live attenuated vaccine based on Towne
strain
There is no one giant step that does it. Its a lot of little
steps. Peter A. Cohen
MUMPS (Parotitis)
Epidemiology
Viral shedding
Saliva 7 days before to 7 days after
appearace of salivary gland swelling
Urine 1st to 14th day after the onset of
salivary gland swelling
Transmission
Direct contact
Airborne droplets
Clinical Manifestations
Subclinical 30-40%
Pancreatitis
Mild or subclinical
Epigastric pain, fever, chills, vomiting,
prostration
Increased amylase
Myocarditis
Arthritis
Migratory polyarthralgia and arthritis in
adults
Affects knees, ankles, shoulders and
wrists
Thyroiditis
Diffuse and tender swelling
Antithyroid antibodies develop
Deafness
1/15,000 cases
Usually unilateral
May be transient or permanent
Ocular complications
Immunity permanent
Prevention
Pics
*May be unilateral or bilateral
Diagnosis
Clinical
Laboratory tests
Elevated serum amylase
Leucopenia with lymphocytosis
Viral isolation saliva, CSF, blood, urine,
brain and other infected tissues
Detection of viral antigen by direct
immunofluorescence
Detection of viral nucleic acid by PCR
Serology
o ELISA
o CFT
o Neutralization
Treatment
Supportive
Arthritis
Nonsteroidal anti-inflammatory agents
Corticosteroid
Complications
Oophoritis
No evidence of infertility